P050038/S044: Arista AH
FDA’s recorded scope: updated water system equipment for the Woburn, MA manufacturing site
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Davol, Inc.. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 29, 2026 to Jul 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LMG appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P050038, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 100 Crossings Blvd., Warwick, RI, 02886. Recorded on P050038/S044, decision dated Jul 15, 2026.
Agent, Absorbable Hemostatic, Non-Collagen Based.
FDA’s recorded scope: updated water system equipment for the Woburn, MA manufacturing site
FDA’s recorded scope: installation of new equipment to automate the filling/weighing and label-application processes, as well as for the upgrade of the HVAC system for the cleanroom used for Arista AH packaging processes
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Davol, Inc. | Class II | Apr 29, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 20, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Arista AHP050038/S044 | Davol, Inc. | PMA supplement | Jul 15, 2026 | FDA |
Arista AHP050038/S043 | Davol, Inc. | PMA supplement | Apr 29, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.